Extending the Gail model for Breast Cancer Risk Prediction to Account for Modifiable Factors in the Italian Population. Calza S, Ferraroni M, Decarli A.

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
UNIVERSITY OF CAMBRIDGE
Unit 14: Measures of Public Health Impact.
Extension Article by Dr Tim Kenny
Assessing Disease Frequency
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Cohort Studies.
In the name of Allah. Development and psychometric Testing of a new Instrument to Measure Affecting Factors on Women’s Behaviors to Breast Cancer Prevention:
Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.
Every Woman, Every Time: Disparities in Breast Cancer Tony L. Weaver, D.O. ALOMA 2015.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
Indicators of health and disease frequency measures
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Breast Imaging Made Brief and Simple
HEAPHY 1 & 2 DIAGNOSTIC James HAYES Fri 30 th Aug 2013 Session 2 / Talk 4 11:33 – 12:00 ABSTRACT To estimate population attributable risks for modifiable.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Spatial Statistics for Cancer Surveillance Martin Kulldorff Harvard Medical School and Harvard Pilgrim Health Care.
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PANCREATIC CANCER RISK: A NESTED CASE-CONTROL STUDY Marie Bradley, Carmel Hughes, Marie Cantwell and Liam Murray.
報 告 者 王瓊琦. postpartum depression : identification of women at risk.
Journal Club Meena Meka MD. Topic Association of Coffee Drinking with Total and Cause-Specific Mortality.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
© 2010 Pearson Prentice Hall. All rights reserved Chapter Data Collection 1.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Associations of Red Meat, Fat, and Protein Intake With Distal Colorectal Cancer Risk 100/5/31 鄒季臻 Nutr Cancer August ; 62(6): 701–709.
1 Breast Cancer Risk Prediction Bernard Rosner Impact of Time-Dependent Risk Factors and Heterogeneity by ER/PR Receptor Status.
When is it safe to forego a CT in kids with head trauma? (based on the article: Identification of children at very low risk of clinically- important brain.
EPIB-591 Screening Jean-François Boivin 29 September
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Canadian Task Force on Preventive Health Care:
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
‘STROKE’ February 2011 Dr Amer Jafar ABHB/Gwent. Decreased Kidney Function  Chronic kidney disease is an important risk factor for development and progression.
Prevalence The presence (proportion) of disease or condition in a population (generally irrespective of the duration of the disease) Prevalence: Quantifies.
Dr Tatiana Macfarlane University of Aberdeen Dental School Scotland 3rd International Conference on Epidemiology & Public Health 2015 Aspirin use and risk.
PERIODIC MEDICAL EXAMINATION BY DR. ANGELA ESOIMEME MBBS, MPH, FWACGP.
Conceptual Issues in Risk Prediction Colin B. Begg Memorial Sloan-Kettering Cancer Center.
Taipei Medical University. Adolescents with Higher Althernate Healthy Eating Index For Taiwan (AHEI-T) Scores Have Lower Blood Lipid Level De-Zhi Weng,
 Nutrition assessment is a comprehensive evaluation carried out by a registered dietitian for defining nutrition status using -medical, social, nutritional,
IRON INTAKE AND RISK OF OVULATORY INFERTILITY: A JOURNAL REPORT Clerk Maria Karla L. Guinto.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Describing the risk of an event and identifying risk factors Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection.
BC Jung A Brief Introduction to Epidemiology - XIII (Critiquing the Research: Statistical Considerations) Betty C. Jung, RN, MPH, CHES.
Effect of process indicators on the episode sensitivity of mammography Tytti Sarkeala, MSc Finnish Cancer Registry Ahti Anttila Matti Hakama Irma Saarenmaa.
Epidemiological Research. Epidemiology A branch of medical science that deals with the incidence, distribution, and control of disease in a population.
Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow,
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Factors associated with maternal smoking during early pregnancy: relationship to low-birth-weight infants and maternal attitude toward their pregnancy.
Date of download: 5/31/2016 From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling.
Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.
Measures of Mortality Dr. Asif Rehman.
Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination A Propensity Score.
Viktor Oskarsson,1 Caroline Nordenvall,2 and Alicja Wolk1
Presenter: Wen-Ching Lan
Review – First Exam Chapters 1 through 5
Suzanne M. Dolwick Grieb, MSPH: University of Florida (UF)
Basic statistics.
Presentation transcript:

Extending the Gail model for Breast Cancer Risk Prediction to Account for Modifiable Factors in the Italian Population. Calza S, Ferraroni M, Decarli A University of Brescia and University of Milan, Italy

The wide international variation in breast cancer (BC) rates suggests that there are potentially modifiable environmental and lifestyle determinants of BC. Two relevant components need to be considered, when the individual estimated probability of cancer is of main concern: “irreversible” - the first is related to the risk factors which are “irreversible” (i.e. genetic factors, age at menarche, age at first birth, number of full-time pregnancies, etc.) “modifiable” -the second is the set of risk factors which are “modifiable”, at least in principle, such as those related to life-style, (i.e. diet, body mass index, alcohol consumption, etc.). Background

Gail et al. (1989) proposed a statistical method (GM) to estimate the individual probability of BC developing, as a function of age and a set of irreversible factors. This model, widely used to optimise intervention studies on BC in USA, is one of the more promising in this field of research. Different authors have evaluated the model in terms of reliability in predicting the number of BC cases expected and validity of assumptions.

The probability of developing BC between the ages a and , for a women who is in risk group i is written as: where the subscript 1 refers to the incidence of BC and 2 to all other causes of death. The model

where : baseline incidence is the baseline incidence of developing BC at age t in the reference group. relative risk is the relative risk of developing BC at age t compared to the baseline group. mortality rate is the mortality rate, at age t, from all causes of death, except BC, in the population. probability of survivingother causes of is the probability of surviving to all other causes of death death to age t.

where: major difficultybaseline hazard without The major difficulty is in the estimation of the baseline breast cancer age-specific hazard, for a subject without known risk factors. It is given by overallincidence rate is the overall age-specific invasive BC incidence rate irrespective of risk group proportion of cases is the proportion of cases in the i- th risk group as estimated by the case-control studies attributable risk is the attributable risk of the specified factors which, in turn, define the different risk groups.

absolute risk This model calculates a woman’s absolute risk of developing BC over various time intervals. It includes information on: age age at menarche age at menarche (  14 years, years, < 12 years) n. of first-degree relatives with BC n. of first-degree relatives with BC ( none, 1, > 1) breast biopsies breast biopsies ( none or unknown, yes) age at first live birth age at first live birth (< 20 years, years, years or nulliparous,  30 years)

The routine use of screening mammography in women 50 years old or older reduces BC mortality by approximately one third. This reduction comes without substantial risks and at an acceptable economic cost. However the use of screening is more controversial in women under the age of 50, for several reasons. Decision about the use of Mammography Targetinghigher risk of BC Targeting mammography to women at higher risk of BC can improve the balance of risks and benefits.

benefit policies of prevention This approach has the potential to define guidelines with relevant implications for cancer prevention and public health. In particular, it allows to stratify women with high risk of BC in subgroups which would benefit from different policies of prevention. “irreversible”“modifiable” The inclusion in the Gail model of other variables, related to modifiable risk factors for BC would allow to disentangle the relative contribution of the two components “irreversible” or “modifiable”, in the individualised probability of developing BC.

The data-sets EPIC-Florence cohort Recruitment was carried out in the period January March 1998 and 10,083 women volunteers, residing in the Provinces of Florence and Prato covered by Cancer Registry, were enrolled in the age interval years, in the Florence section of EPIC prospective study on diet and cancer. Detailed information was collected about dietary and life-style habits, reproductive history and family history for BC, for each woman included in the study.

10,083 women volunteers residing in the provinces of Florence and Prato in the age interval years 10 subjects lost to follow-up 30 subjects prevalent BC cases 10,031 subjects included in the analysis 12 subjects incident BC cases but diagnosed whitin 6 months from the date of recruitment A total of 142 incident invasive BC cases occurred during the period of follow-up

Multicentre case-control study The case-control study was conducted between June 1991 and February 1994 in six Italian areas. Cases Cases were 2569 women, aged years ( median age 55 years) admitted to the major teaching and general hospitals of the study areas with histologically confirmed BC diagnosed within the year before interview, and no previous history of cancer. Controls Controls were 2588 women, aged years ( median age 56 years) and admitted to hospitals in the same catchment areas of cases for acute conditions.

Both data-sets include information on sociodemographic charateristics, such as age, education, occupation end socio-economic indicators, lifelong smoking habits, physical activity, anthropometric measures, alcohol consumption, dietary habits, personal medical history and selected questions regarding family history of cancer. A validated food frequency questionnaire was used to assess the usual diet in order to estimate the mean daily intake of calories and selected nutrients.

absolute risks different models Individualized absolute risks for BC in the EPIC-Florence cohort were estimated according different models, that differ in the following aspects: age-specific invasive BC rates, r i (t) and AR(t) are those derived from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute; US-Gail model It-Gail model r i (t) are derived by the multicentre case-control study on diet and BC conducted in Italy, and h 1 (t), h 2 (t) are obtained from the Florence Cancer Registry. The estimated r i (t) were obtained by means of a logistic regression model including the same variables as in the US-Gail model.

alcohol consumptionmonounsaturated fats intake Different It-Gail models were fitted including dietary variables. In particular we investigated the role of alcohol consumption and monounsaturated fats intake. Gail model extension proportional different risk factors The aim is to quantify the proportional relevance of the different risk factors in defining BC risk.

Validation of the model

Gail model extension

Conclusions Gail model is reasonably valid in Italy: our projected probabilities of developing BC have been validated on women included in a screening programme. Gail model can be improved for use in populations other than American one, by using BC incidence and RR estimates for risk factors of interest which are more appropriate to the target population. Gail model structure including potentially modifiable factors can be an important tool in BC risk counselling. The counsellor has the opportunity to look at the lifestyle of the women and possibly suggest that this be modified as an alternative or in conjunction with chemioprevention.

Acknowledgements This work was conducted with the contributions of the Associazione Italiana per la Ricerca sul Cancro and the Italian Ministry of Education (PRIN 2003)

Estimates of probabilities (% and 95% bootstrap confidence intervals) of developing breast cancer for selected group of subjects

- Breast density is generally higher in younger women and screening mammography is less likely to detect early BC at a curable stage. - More false positive tests. - Women under 50 are less likely to have BC. Fewer women in this age group will benefit from screening. - Cost of mammography per year of life saved is approximately Euro.